Clindahit Capsule 10's

How does the drug interact with Clindahit Capsule:
Taking Clindahit Capsule with Botulinum toxin can increase the risk or severity of side effects.

How to manage the interaction:
Taking Clindahit Capsule with Botulinum toxin together can result in an interaction, they can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact a doctor immediately. Do not discontinue any medications without consulting a doctor.

How does the drug interact with Clindahit Capsule:
Taking Clindahit Capsule with clarithromycin may increase the effects of Clindahit Capsule.

How to manage the interaction:
Although there is a possible interaction, Clindahit Capsule can be taken with clarithromycin if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhea. Do not discontinue the medication without consulting a doctor.

How does the drug interact with Clindahit Capsule:
Concomitant use of Clindahit Capsule with indinavir may increase the effects of Clindahit Capsule.

How to manage the interaction:
Although there is a possible interaction, Clindahit Capsule can be taken with indinavir if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain, or diarrhoea.

How does the drug interact with Clindahit Capsule:
Co-administration of Boceprevir together with Clindahit Capsule can increase the effects of Clindahit Capsule.

How to manage the interaction:
Although there is a possible interaction between Clindahit Capsule and Boceprevir, you can take these medicines together if prescribed by your doctor. If you have ongoing feelings of sickness, throwing up, having loose stools, or pain in your stomach, it's important to contact your doctor right away. Do not stop using any medications without a doctor's advice.

How does the drug interact with Clindahit Capsule:
When Clindahit Capsule is taken with Fosphenytoin, it can cause the body to process Clindahit Capsule faster.

How to manage the interaction:
Although there is a possible interaction between Clindahit Capsule and Fosphenytoin, you can take these medicines together if prescribed by your doctor. If you notice any symptoms like sudden drowsiness, fatigue, confusion, itching, burning, or tingling sensation, abnormal body movements, or loss of coordination, make sure to contact your doctor right away. Do not stop using any medications without first talking to your doctor.

How does the drug interact with Clindahit Capsule:
Coadministration of use of Clindahit Capsule with ketoconazole can increase the effects of Clindahit Capsule.

How to manage the interaction:
Although there is a possible interaction, Clindahit Capsule can be taken with ketoconazole if prescribed by the doctor. Consult the prescriber if you experience persistent vomiting, nausea, abdominal pain or diarrhea. Do not discontinue any medication without consulting a doctor. Do not discontinue any medication without consulting a doctor.

How does the drug interact with Clindahit Capsule:
When taken in combination, Clindahit Capsule can lower the amount or action of estradiol.

How to manage the interaction:
Co-administration of Estradiol with Clindahit Capsule can result in an interaction, but it can be taken if a doctor has advised it. Do not stop using any medications without a doctor's advice.

How does the drug interact with Clindahit Capsule:
Co-administration of Clindahit Capsule with Bacitracin may increase the risk of kidney and/or nerve damage.

How to manage the interaction:
Although there is a possible interaction, Clindahit Capsule can be taken with bacitracin if prescribed by the doctor. Consult the prescriber if you experience signs and symptoms of kidney damage such as sudden weight gain or weight loss, nausea, vomiting, fluid retention, loss of appetite, increased or decreased urination, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. Let your doctor know if you develop seizures; hearing problems; or numbness, burning or tingling in your hands and feet. If you develop diarrhoea or vomiting during treatment with these medications, drink plenty of fluids to prevent dehydration, as dehydration may harm the kidney.

How does the drug interact with Clindahit Capsule:
Co-administration of Clindahit Capsule may reduce the activity of the cholera vaccine.

How to manage the interaction:
Talk to your doctor before receiving the Cholera vaccine if you are currently being treated with Clindahit Capsule or have been treated within the last 14 days. To ensure adequate vaccine response, you should not receive cholera vaccine until at least 14 days after you complete antibiotic therapy. Do not discontinue the medication without consulting a doctor.

How does the drug interact with Clindahit Capsule:
Co-administration of Clindahit Capsule with Atracurium can increase the risk of muscle weakness.

How to manage the interaction:
Taking Clindahit Capsule with Atracurium together can possibly result in an interaction, but it can be taken if a doctor has advised it. "Clindahit Capsule can affect the muscles and nerves in your body. When used with other medications that also affect the muscles and nerves, it can cause a serious problem called neuromuscular blockade. If you have trouble breathing or can't breathe at all, please call your doctor right away." Do not stop using any medications without a doctor's advice.

How does the disease interact with Clindahit Capsule:
Almost all antibacterial medications have been associated with reports of Clostridioides difficile-associated diarrhoea (CDAD), formerly known as pseudomembranous colitis. It can vary from mild diarrhoea to deadly colitis.

How to manage the interaction:
Clostridioides difficile-associated diarrhea (CDAD) ranging from mild diarrhoea to colitis has been reported during treatment with antibacterial agents. Therapy should be administered cautiously in patients with history of gastrointestinal disease, particularly colitis and pseudomembranous colitis. Appropriate fluid and electrolyte management, protein supplementation, and antibacterial treatment of C difficile is advised.

How does the disease interact with Clindahit Capsule:
Benzyl alcohol is frequently used as a preservative in the formulation of multidose vials for parenteral medicines. Manufacturers of pharmaceuticals believe that using them in neonates, especially preterm and underweight newborns, is contraindicated. In low birth weight preterm newborns, the use of benzyl alcohol in bacteriostatic saline intravascular flush and endotracheal tube lavage solutions has been linked to mortality and serious respiratory and metabolic problems.

How to manage the interaction:
Parenteral medications containing benzyl alcohol as a preservative are contraindicated in neonates, particularly premature infants and infants of low birth weight.

How does the disease interact with Clindahit Capsule:
The liver is the primary site of Clindahit Capsule metabolism. Patients with significantly impaired hepatic function may have a rise in the blood concentration of Clindahit Capsule and a prolongation of the half-life. Additionally, the drug's usage may result in abnormal liver enzyme levels and jaundice. Patients with liver problems should receive Clindahit Capsule therapy with caution. When given every 8 hours, dosage modifications might not be required. However, with high-dose therapy, serum concentrations should be observed, and during prolonged therapy, regular liver function tests should be carried out.

How to manage the interaction:
Clindahit Capsule is primarily metabolized by the liver. Therapy with Clindahit Capsule should be administered cautiously in patients with liver disease. Serum concentrations should be monitored during high-dose therapy, and periodic liver function tests should be performed during prolonged therapy.

How does the disease interact with Clindahit Capsule:
Clindahit Capsule is partially removed by the kidney. Clindahit Capsule should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindahit Capsule concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.

How to manage the interaction:
Therapy with Clindahit Capsule should be administered cautiously in patients with severely impaired renal function. Serum Clindahit Capsule concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.

How does the disease interact with Clindahit Capsule:
Clindahit Capsule is partially removed by the kidney. Clindahit Capsule should be used with caution in individuals with significantly impaired renal function. Dosage changes are probably to be required. Serum Clindahit Capsule concentrations should be monitored throughout high-dose therapy, and renal function tests should be conducted on a regular basis during extended medication.

How to manage the interaction:
Therapy with Clindahit Capsule should be administered cautiously in patients with severely impaired renal function. Serum Clindahit Capsule concentrations should be monitored during high-dose therapy, and periodic renal function tests should be performed during prolonged therapy.